top of page
GT Logo White.png

2024
American Cancer Society Bright Edge Golden Ticket

Apply by January 23, 2025

Offered by:

BrightEdge_RGB.png

Powered by:

Research_Bridge_Partners.jpg

Hosted by:

ACS Bright Edge, supported by AbbVie, LH Capital, and Research Bridge Partners are sponsoring to award 1 Golden Ticket at BioLabs Pegasus Park. 

Each Golden Ticket provides one year of fully paid individual bench space and membership at a fully equipped laboratory designed to accelerate early-stage oncology companies with promising new therapies, preferably with platforms that can be applied to multiple targets, that could benefit patients with hematologic and solid tumor malignancies.

Application

Application Process

The official application process can be found below. Please read and verify your availability before submitting your application. 

calendar.png

Application

Complete the application form and upload a non-confidential pitch deck for this competition.

printer.png

Terms & Conditions

Each applicant must acknowledge that they have read the official Terms and Conditions and they fully agrees and accept them. 

lightbulb.png
Benefits

Golden Ticket Benefits

BioLabs035.jpg

1-year membership, lab bench and office space

to de-risk your technology and scale your business 

TechFW

Content rich events and programming

with ecosystem partners for local startups

BioLabs_Thermo_PR_Collaboration.png

Unparalleled suite of laboratory equipment

to execute your research and development

christina-wocintechchat-com-DcHbAegafZg-unsplash.jpg

  $25,000 Cash award

to support your research 

MicrosoftTeams-image4072ff6cdfbe3f3b659bf511b8cddfd93d42c64b15b1c4048053eed0e94325b7.png

Gateway to a

potential collaboration

with ACS Bright Edge, and AbbVie

Eligibility Snapshot
ACS Bright Edge, AbbVie, LH Capital, and Research Bridge Partners are looking for early-stage biotech companies that fit the following criteria: 

Early Stage

Oncology therapeutics

Able to take space at BioLabs Pegasus Park

Eligibility

Focus Areas
Early-stage oncology companies with promising new therapies, preferably with platforms that can be applied to multiple targets, that could benefit patients with hematologic and solid tumor malignancies. Areas of interest include :

Novel or differentiated programs targeting prioritized areas of tumor biology, including: 

A.Selective tumor cell killing 

B.Oncogenic signaling  pathways

C.Immuno-oncology

Targeted biologics and next-generation cell therapies (in situ/in vivo)

Novel approaches to small molecules, including technologies that enable targeting of hard-to-drug target classes 

Precision Medicine

App Process

The Application Process

01

Submit applications by
January 23, 2025

02

A subset of applications will be identified as finalist by the contest judges by
February 10, 2025

03

Finalists will present their company & scientific concept at Pegasus Park
on March 11, 2025

04

1 award will be granted
Good luck!

Judging criteria

Contact Us

If you have any questions regarding this competition, contact 

ryan.margolis@cancer.org

If you have any questions about BioLabs, contact

goldenticket@biolabs.io

Biolabs - 04_edited.jpg
bottom of page